La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Zhejiang Gongdong Medical Technology Croissance future
Future contrôle des critères 5/6
Zhejiang Gongdong Medical Technology is forecast to grow earnings and revenue by 32.9% and 24% per annum respectively. EPS is expected to grow by 32.9% per annum. Return on equity is forecast to be 16.1% in 3 years.
Informations clés
32.9%
Taux de croissance des bénéfices
32.9%
Taux de croissance du BPA
Medical Equipment croissance des bénéfices | 22.5% |
Taux de croissance des recettes | 24.0% |
Rendement futur des capitaux propres | 16.1% |
Couverture par les analystes | Low |
Dernière mise à jour | 13 Jun 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Zhejiang Gongdong Medical Technology Co., Ltd.'s (SHSE:605369) P/E Still Appears To Be Reasonable
Jun 07Estimating The Intrinsic Value Of Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369)
Mar 28Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369) Looks Just Right With A 27% Price Jump
Mar 06Zhejiang Gongdong Medical Technology (SHSE:605369) Is Reinvesting At Lower Rates Of Return
Feb 27Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 2,093 | 382 | 491 | 544 | 2 |
12/31/2025 | 1,734 | 314 | 364 | 425 | 2 |
12/31/2024 | 1,436 | 253 | 196 | 415 | 2 |
3/31/2024 | 1,021 | 125 | 89 | 188 | N/A |
12/31/2023 | 975 | 109 | 64 | 185 | N/A |
9/30/2023 | 1,002 | 106 | 112 | 189 | N/A |
6/30/2023 | 1,128 | 176 | 136 | 248 | N/A |
3/31/2023 | 1,347 | 260 | 143 | 268 | N/A |
12/31/2022 | 1,469 | 326 | 111 | 283 | N/A |
9/30/2022 | 1,527 | 367 | 138 | 382 | N/A |
6/30/2022 | 1,417 | 344 | 3 | 285 | N/A |
3/31/2022 | 1,280 | 327 | 32 | 350 | N/A |
12/31/2021 | 1,194 | 311 | 97 | 373 | N/A |
9/30/2021 | 1,088 | 319 | 326 | 269 | N/A |
6/30/2021 | 1,068 | 313 | 208 | 379 | N/A |
3/31/2021 | 989 | 281 | 177 | 304 | N/A |
12/31/2020 | 830 | 226 | 134 | 242 | N/A |
9/30/2020 | 744 | 191 | -160 | 220 | N/A |
6/30/2020 | 638 | 155 | 58 | 142 | N/A |
3/31/2020 | 529 | 113 | 20 | 113 | N/A |
12/31/2019 | 553 | 114 | 20 | 122 | N/A |
12/31/2018 | 483 | 86 | 67 | 102 | N/A |
12/31/2017 | 431 | 54 | N/A | 86 | N/A |
12/31/2016 | 371 | 61 | N/A | 86 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: 605369's forecast earnings growth (32.9% per year) is above the savings rate (2.9%).
Bénéfices vs marché: 605369's earnings (32.9% per year) are forecast to grow faster than the CN market (21.9% per year).
Croissance élevée des bénéfices: 605369's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: 605369's revenue (24% per year) is forecast to grow faster than the CN market (13.4% per year).
Croissance élevée des revenus: 605369's revenue (24% per year) is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: 605369's Return on Equity is forecast to be low in 3 years time (16.1%).